All Work

Chris Lange

Good News for Stem Cell Transplants

Akari Therapeutics shares jumped on Wednesday after the firm announced that the FDA has granted Fast Track designation for its stem cell transplant treatment.

Chris Lange · 7 years ago

Tilray’s Q2: A Swing and a Miss

Tilray released its second quarter financial results after the markets closed on Tuesday. The company said that it had a net loss of $0.36 per share and $45.9 million in revenue, compared with consensus…

Chris Lange · 7 years ago

China Tariff Delay Comes to Market’s Rescue

The S&P 500 and Dow are turning it around after a two-day losing streak. This comes on the heels of news that the United States has removed some items from the list of China…

Chris Lange · 7 years ago

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.

Chris Lange · 7 years ago

Short Sellers Make a Move on Big Biotechs

The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.

Chris Lange · 7 years ago

Semiconductor Short Sellers Hike Their Bets

The July 31 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.

Chris Lange · 7 years ago

China Tariff Delay Comes to Market’s Rescue

The S&P 500 and Dow are turning it around after a two-day losing streak. This comes on the heels of news that the United States has removed some items from the list of China…

Chris Lange · 7 years ago

Is Amarin’s Cardio Trial in Trouble?

Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application.

Chris Lange · 7 years ago